2025 - Our research and strategies recognized

The Research Council of Norway conducted a nation-wide Evaluation of Medicine and Health for the 11-year period 2012-2022. The evaluation reports were finalized April 2025 and our Department (Life Science panel 2c) achieved maximum scores on all dimensions (report), including quality of research and publications, organization and strategies to support excellent research, and societal contribution. We appreciate this recognition of our benchmark research accomplishments, as well as our active profile in education and training of young researchers, networks of interdisciplinary collaborations, development of research resources and technology platforms, and long-term strategy to build complementary research teams.

Two new group leaders were appointed in 2025. The Department was supported by the Institute leadership with a group leader position in Cancer Informatics, and Bjarne Johannessen was appointed. He will have shared responsibilities between research and IT infrastructure development. Anita Sveen fulfils all criteria for a group leader position at the ICR, and advanced from her role in the Lothe lab to establish a new group in Computational Oncology. The leader of the Epigenetics group, Guro E. Lind, resumed to full position after serving for six years as president of the Norwegian Association for researchers. The Genome Biology Group expanded their project portfolio with childhood cancers, under the responsibility of senior researcher Ioannis Panagopoulos.